PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
16-Dec-2022 Körber Partner Program "PAS-X MSI Plug & Produce": The onoff AG receives the "Ready" certification Körber
16-Dec-2022 Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE
15-Dec-2022 STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE STRATEC SE
15-Dec-2022 PM Society Awards - NEW CATEGORY PM Society
15-Dec-2022 Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis B3C newswire
15-Dec-2022 T-CURX GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco B3C newswire
15-Dec-2022 NICE issues positive recommendation to expand use of Ofev® (nintedanib) in idiopathic pulmonary fibrosis Boehringer Ingelheim
15-Dec-2022 Qlucore participates in major EU project to prevent cardiovascular diseases Qlucore
15-Dec-2022 UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration UCB
15-Dec-2022 NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture Sciad Newswire
15-Dec-2022 Axplora announces the grant of a Pharmaceutical Establishment License for its Le Mans site Axplora
15-Dec-2022 ProtonDx Revs Up European Commercial Expansion with New Head of Sales B3C newswire
15-Dec-2022 Cannovum AG share enters Xetra trading Cannovum AG
15-Dec-2022 Defence Therapeutics Inc.: DEFENCE'S mRNA WITH ACCUMTM FOR CANCER VACCINES UPDATE Defence Therapeutics Inc.
15-Dec-2022 Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding Verseon International Corporation
14-Dec-2022 CureVac Members of Management Sell Shares to Cover Tax Obligations from Long Term Incentive Program CureVac
14-Dec-2022 Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture  SAE Media Group
14-Dec-2022 Douglas GmbH: Release of results for the 4th quarter and full year 2021/22 (ending 30 September 2022) on 20 December 2022 Douglas GmbH
14-Dec-2022 Abivax to attend the J.P. Morgan 41st Annual Healthcare Conference ABIVAX
14-Dec-2022 Heidelberg Pharma AG: Encouraging Clinical Data from Two Antibody Drug Conjugates Based on Heidelberg Pharma’s ATAC Technology Presented at the ASH Annual Meeting 2022 Heidelberg Pharma AG